dc.contributor.author | Erkek, E | |
dc.contributor.author | Ayaslioglu, E | |
dc.contributor.author | Erkek, AB | |
dc.contributor.author | Kurtipek, GS | |
dc.contributor.author | Bagci, Y | |
dc.date.accessioned | 2020-06-25T17:40:23Z | |
dc.date.available | 2020-06-25T17:40:23Z | |
dc.date.issued | 2005 | |
dc.identifier.issn | 0815-9319 | |
dc.identifier.uri | https://doi.org/10.1111/j.1440-1746.2005.03903.x | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/3420 | |
dc.description | ERKEK, BULENT/0000-0002-9041-341X | en_US |
dc.description | WOS: 000231611700006 | en_US |
dc.description | PubMed: 16174066 | en_US |
dc.description.abstract | Background and Aims: Hepatitis B virus infection is an important public health problem in Turkey. Although hepatitis B vaccination is regarded as safe and effective for the general population, recommendations for hepatitis B immunization in patients with Behcet's disease are not clear. The aim of the present study was to elucidate the response of patients with Behcet's disease to hepatitis B vaccination and to determine whether hepatitis B vaccination has any adverse effects on the course of the disease. Methods: Thirteen patients with Behcet's disease and 15 healthy individuals were enrolled into a prospective study. All subjects received the 3-dose series of routine hepatitis B vaccine. Anti-hepatitis B surface response was evaluated 1-3 months after the third dose of vaccine. Results: The responder rates for patient and control groups were 12/13 (92.8%) and 14/15 (93.8%), respectively. Statistical analysis showed no significant difference between the two groups in terms of both the responder rates and mean antibody titers. Conclusions: These preliminary findings might suggest that the majority of patients with Behcet's disease develop protective antibody response after hepatitis B vaccination and that the immune response against hepatitis B surface antigen is adequate, efficient and intact. (C) 2005 Blackwell Publishing Asia Pty Ltd. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Blackwell Publishing | en_US |
dc.relation.isversionof | 10.1111/j.1440-1746.2005.03903.x | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Behcet's disease | en_US |
dc.subject | hepatitis B infection | en_US |
dc.subject | hepatitis B vaccination | en_US |
dc.subject | response | en_US |
dc.subject | side-effects | en_US |
dc.title | Response to vaccination against hepatitis B in patients with Behcet's disease | en_US |
dc.type | article | en_US |
dc.contributor.department | Kırıkkale Üniversitesi | en_US |
dc.identifier.volume | 20 | en_US |
dc.identifier.issue | 10 | en_US |
dc.identifier.startpage | 1508 | en_US |
dc.identifier.endpage | 1511 | en_US |
dc.relation.journal | Journal Of Gastroenterology And Hepatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |